HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia.
Benjamin J LeeShawn P GriffinJean DohAlexandre ChanStefan O CiureaDeepa JeyakumarAngela G FleischmanKiran NaqviNicholas R PannunzioSusan M O'BrienPiyanuch KongtimPublished in: European journal of haematology (2023)
Hispanic patients with B-cell ALL had worse EFS with a PEG-CAR as compared with HyperCVAD. Future studies will aim to confirm these findings and establish a tailored treatment approach for this high-risk population.